Agile Therapeutics Inc (AGRX)

$1.51 0.00 (N/A)
Market Cap 10.35M
Revenue (ttm) 19.59M
Net Income (ttm) -14.47M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 120,900
Avg Vol 178,234
Day's Range N/A - N/A
Shares Out 6.86M
Stochastic %K 88%
Beta 1.58
Analysts Strong Sell
Price Target $12.00
NVDAistheSHIZ
NVDAistheSHIZ Jun. 30 at 6:00 PM
$AGRX lmfao...hunt this guy down...i lost close to 50K because of this dipshit and now they merged it with InSud after they screwed everyone of their retail shareholders over and now he works at a cushy job at Medina Health? Fuck this asshole...hunt him down
1 · Reply
Profitrip
Profitrip May. 28 at 8:58 AM
$SGBX shorted the pop / not $AGRX type o
0 · Reply
Profitrip
Profitrip May. 28 at 8:33 AM
$AGRX ss the pop
0 · Reply
JasonCO
JasonCO May. 9 at 6:42 PM
$AGRX on watch
0 · Reply
JMJTrading
JMJTrading May. 2 at 2:50 PM
$BLMZ Unbelievable setup here, the fueling is unreal, 30's soon! $ELOX $AGRX
0 · Reply
Best4yourbuck
Best4yourbuck Mar. 24 at 10:34 AM
$AGRX f this stock lost so much in this
0 · Reply
Stock_Guy_69
Stock_Guy_69 Feb. 24 at 9:04 PM
$AGRX $SENS So blessed! 🤣
1 · Reply
dln101
dln101 Feb. 6 at 1:35 PM
$AVGR depending on where it opens may get some for a bounce 🤔 $AGRX 🔥📈
1 · Reply
NVDAistheSHIZ
NVDAistheSHIZ Feb. 4 at 2:23 PM
$CODX $AGRX https://www.stocktitan.net/news/TNXP/tonix-pharmaceuticals-announces-1-for-100-reverse-stock-py8xwkged9yd.html This is the type of BS that happens in the drug world...don't invest in this sector...never
1 · Reply
NVDAMillionaire
NVDAMillionaire Jan. 25 at 3:00 PM
$AGRX Agile Therapeutics, Inc. (AGRX): Executing on Commercialization Strategy, Poised for Continued Growth https://beyondspx.com/article/agile-therapeutics-inc-agrx-executing-on-commercialization-strategy-poised-for-continued-growth
0 · Reply
Latest News on AGRX
Agile Therapeutics Inc. Announces Completion of Acquisition by Insud Pharma, S.L.

Aug 26, 2024, 5:05 PM EDT - 11 months ago

Agile Therapeutics Inc. Announces Completion of Acquisition by Insud Pharma, S.L.

Agile Leadership for Pharma and Biopharma Professionals in a Hybrid World: 2-Day Training Course (Online) November 18-19, 2024 - Become Competent and Familiar in a Range of Well-Recognised Leadership Techniques

Aug 7, 2024, 4:22 AM EDT - 1 year ago

Agile Leadership for Pharma and Biopharma Professionals in a Hybrid World: 2-Day Training Course (Online) November 18-19, 2024 - Become Competent and Familiar in a Range of Well-Recognised Leadership Techniques

AGILE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Agile Therapeutics, Inc. - AGRX

Jun 28, 2024, 6:14 PM EDT - 1 year ago

AGILE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Agile Therapeutics, Inc. - AGRX

Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.

Jun 26, 2024, 7:45 AM EDT - 1 year ago

Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.

Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

May 15, 2024, 4:10 PM EDT - 1 year ago

Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

Agile Therapeutics, Inc. (AGRX) Q4 2023 Earnings Call Transcript

Mar 28, 2024, 10:46 AM EDT - 1 year ago

Agile Therapeutics, Inc. (AGRX) Q4 2023 Earnings Call Transcript

Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update

Mar 28, 2024, 8:05 AM EDT - 1 year ago

Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update

Agile Therapeutics Announces Delisting from Nasdaq

Mar 25, 2024, 4:30 PM EDT - 1 year ago

Agile Therapeutics Announces Delisting from Nasdaq

Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024

Mar 21, 2024, 6:35 AM EDT - 1 year ago

Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024

Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024

Mar 20, 2024, 8:15 AM EDT - 1 year ago

Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024

Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution

Mar 13, 2024, 7:31 AM EDT - 1 year ago

Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution

Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds

Feb 22, 2024, 9:01 AM EST - 1 year ago

Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds

Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders' Equity Continued Listing Requirement & Provides Performance Update

Feb 15, 2024, 4:30 PM EST - 1 year ago

Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders' Equity Continued Listing Requirement & Provides Performance Update

The Biden-Harris Administration Announces New Guidance to Enable Expanded Access to All FDA-Approved Contraceptives Without Cost

Jan 23, 2024, 9:29 AM EST - 1 year ago

The Biden-Harris Administration Announces New Guidance to Enable Expanded Access to All FDA-Approved Contraceptives Without Cost

Agile Therapeutics Provides Update on Actions Being Taken to Strengthen the Affordable Care Act's No-Cost Contraceptive Coverage Requirement

Dec 12, 2023, 8:01 AM EST - 1 year ago

Agile Therapeutics Provides Update on Actions Being Taken to Strengthen the Affordable Care Act's No-Cost Contraceptive Coverage Requirement

Agile Therapeutics Posts Growth In Third Quarter Results, Reiterates Confidence In Target of $25M Net Revenue, Positive Cash Flow In 2024

Nov 22, 2023, 9:00 AM EST - 1 year ago

Agile Therapeutics Posts Growth In Third Quarter Results, Reiterates Confidence In Target of $25M Net Revenue, Positive Cash Flow In 2024

Agile Therapeutics, Inc. (AGRX) Q3 2023 Earnings Call Transcript

Nov 9, 2023, 1:14 PM EST - 1 year ago

Agile Therapeutics, Inc. (AGRX) Q3 2023 Earnings Call Transcript

Agile Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Nov 9, 2023, 8:05 AM EST - 1 year ago

Agile Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Agile Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on Thursday, November 9, 2023

Oct 26, 2023, 8:05 AM EDT - 1 year ago

Agile Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on Thursday, November 9, 2023

Agile Therapeutics Reports an Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)

Oct 4, 2023, 4:30 PM EDT - 1 year ago

Agile Therapeutics Reports an Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)

Agile Therapeutics (NASDAQ: AGRX) Upgraded To “Buy” Rating By Analysts At Maxim Group

Sep 28, 2023, 9:00 AM EDT - 1 year ago

Agile Therapeutics (NASDAQ: AGRX) Upgraded To “Buy” Rating By Analysts At Maxim Group

Agile Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Sep 5, 2023, 8:05 AM EDT - 2 years ago

Agile Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Agile Says It's On Track To Hit $25-$30 Million Net Annual Revenue After A Strong Performance In Its Second Quarter

Aug 17, 2023, 9:00 AM EDT - 2 years ago

Agile Says It's On Track To Hit $25-$30 Million Net Annual Revenue After A Strong Performance In Its Second Quarter

Agile Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Aug 9, 2023, 8:05 AM EDT - 2 years ago

Agile Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Agile Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Plan Updates on Wednesday, August 9, 2023

Jul 26, 2023, 8:30 AM EDT - 2 years ago

Agile Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Plan Updates on Wednesday, August 9, 2023

This Reproductive Health Company's Weekly Contraceptive Patch Can Reach Millions of Women Thanks to a Partnership With Afaxys

Jul 19, 2023, 9:00 AM EDT - 2 years ago

This Reproductive Health Company's Weekly Contraceptive Patch Can Reach Millions of Women Thanks to a Partnership With Afaxys

Agile Sees Renewed Hope For Even Broader Adoption Of Its Weekly Birth Control Patch After Biden's Latest Executive Order Expanding Contraceptive Coverage

Jul 11, 2023, 9:15 AM EDT - 2 years ago

Agile Sees Renewed Hope For Even Broader Adoption Of Its Weekly Birth Control Patch After Biden's Latest Executive Order Expanding Contraceptive Coverage

H.C. Wainwright Reiterates Buy Rating For Agile Therapeutics (NASDAQ: AGRX), Citing Growing Demand For Twirla, A Weekly Low Dose Birth Control Patch

Jul 5, 2023, 9:00 AM EDT - 2 years ago

H.C. Wainwright Reiterates Buy Rating For Agile Therapeutics (NASDAQ: AGRX), Citing Growing Demand For Twirla, A Weekly Low Dose Birth Control Patch

This Women's Healthcare Company Raised $7.5 Million In A Public Offering And Says It's Targeting $25 To $30 Million Net Revenue By End Of 2023

Jul 3, 2023, 9:00 AM EDT - 2 years ago

This Women's Healthcare Company Raised $7.5 Million In A Public Offering And Says It's Targeting $25 To $30 Million Net Revenue By End Of 2023

Agile Therapeutics Expects Its Innovative Once-A-Week Birth Control Patch To Drive Revenues Of $25-30 Million In 2023 - What Is The Hype All About?

Jun 30, 2023, 9:00 AM EDT - 2 years ago

Agile Therapeutics Expects Its Innovative Once-A-Week Birth Control Patch To Drive Revenues Of $25-30 Million In 2023 - What Is The Hype All About?

Agile Therapeutics Announces the Availability of Twirla® to MMCAP Infuse Members

Jun 26, 2023, 8:01 AM EDT - 2 years ago

Agile Therapeutics Announces the Availability of Twirla® to MMCAP Infuse Members

Agile Therapeutics Commends the Biden Administration's Commitment to Strengthening Access to Affordable, High-Quality Contraception and Family Planning Services

Jun 23, 2023, 12:05 PM EDT - 2 years ago

Agile Therapeutics Commends the Biden Administration's Commitment to Strengthening Access to Affordable, High-Quality Contraception and Family Planning Services

Agile Therapeutics Announces the Availability of Twirla® through FPA Women's Health

Jun 15, 2023, 4:05 PM EDT - 2 years ago

Agile Therapeutics Announces the Availability of Twirla® through FPA Women's Health

Agile Therapeutics Announces New Agreement with vitaCare® Prescription Services to Improve Access to Twirla®

Jun 13, 2023, 4:05 PM EDT - 2 years ago

Agile Therapeutics Announces New Agreement with vitaCare® Prescription Services to Improve Access to Twirla®

Agile Therapeutics Announces Closing of $7.5 Million Public Offering

May 25, 2023, 4:05 PM EDT - 2 years ago

Agile Therapeutics Announces Closing of $7.5 Million Public Offering

Agile Therapeutics Announces Pricing of $7.5 Million Public Offering

May 22, 2023, 8:00 PM EDT - 2 years ago

Agile Therapeutics Announces Pricing of $7.5 Million Public Offering

Agile Therapeutics, Inc. (AGRX) Q1 2023 Earnings Call Transcript

May 12, 2023, 7:09 PM EDT - 2 years ago

Agile Therapeutics, Inc. (AGRX) Q1 2023 Earnings Call Transcript

Agile Therapeutics Reports First Quarter 2023 Financial Results And Provides Corporate Update

May 11, 2023, 4:05 PM EDT - 2 years ago

Agile Therapeutics Reports First Quarter 2023 Financial Results And Provides Corporate Update

Agile Therapeutics to Report First Quarter 2023 Financial Results and Provide Business Update on Thursday, May 11, 2023

May 8, 2023, 8:00 AM EDT - 2 years ago

Agile Therapeutics to Report First Quarter 2023 Financial Results and Provide Business Update on Thursday, May 11, 2023

Agile Therapeutics Announces Preliminary Expectations for First Quarter 2023

Apr 28, 2023, 8:01 AM EDT - 2 years ago

Agile Therapeutics Announces Preliminary Expectations for First Quarter 2023

Agile Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement

Apr 26, 2023, 9:01 AM EDT - 2 years ago

Agile Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement

Agile Therapeutics Announces 1-For-50 Reverse Stock Split

Apr 10, 2023, 4:30 PM EDT - 2 years ago

Agile Therapeutics Announces 1-For-50 Reverse Stock Split

Agile Therapeutics, Inc (AGRX) Q4 2022 Earnings Call Transcript

Mar 24, 2023, 12:31 PM EDT - 2 years ago

Agile Therapeutics, Inc (AGRX) Q4 2022 Earnings Call Transcript

Agile Therapeutics Reports Fourth Quarter & Full Year 2022 Financial Results and Provides Corporate Update

Mar 22, 2023, 4:05 PM EDT - 2 years ago

Agile Therapeutics Reports Fourth Quarter & Full Year 2022 Financial Results and Provides Corporate Update

Agile Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on Wednesday, March 22, 2023

Mar 21, 2023, 9:05 AM EDT - 2 years ago

Agile Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on Wednesday, March 22, 2023

Agile Therapeutics Granted 180-Day Extension by Nasdaq to Meet the Minimum Bid Price Requirement

Feb 27, 2023, 8:31 AM EST - 2 years ago

Agile Therapeutics Granted 180-Day Extension by Nasdaq to Meet the Minimum Bid Price Requirement

Corium Pharma Solutions Names Ernie De Paolantonio as Chief Financial Officer

Feb 15, 2023, 8:00 AM EST - 2 years ago

Corium Pharma Solutions Names Ernie De Paolantonio as Chief Financial Officer

PG

Corium Pharma Solutions Names Two Industry Veterans to its Executive Team

Feb 9, 2023, 8:00 AM EST - 2 years ago

Corium Pharma Solutions Names Two Industry Veterans to its Executive Team

PG

Agile Therapeutics Provides Clinical Update on Twirla and Status of Pipeline Evaluation

Feb 1, 2023, 8:01 AM EST - 2 years ago

Agile Therapeutics Provides Clinical Update on Twirla and Status of Pipeline Evaluation

NVDAistheSHIZ
NVDAistheSHIZ Jun. 30 at 6:00 PM
$AGRX lmfao...hunt this guy down...i lost close to 50K because of this dipshit and now they merged it with InSud after they screwed everyone of their retail shareholders over and now he works at a cushy job at Medina Health? Fuck this asshole...hunt him down
1 · Reply
Profitrip
Profitrip May. 28 at 8:58 AM
$SGBX shorted the pop / not $AGRX type o
0 · Reply
Profitrip
Profitrip May. 28 at 8:33 AM
$AGRX ss the pop
0 · Reply
JasonCO
JasonCO May. 9 at 6:42 PM
$AGRX on watch
0 · Reply
JMJTrading
JMJTrading May. 2 at 2:50 PM
$BLMZ Unbelievable setup here, the fueling is unreal, 30's soon! $ELOX $AGRX
0 · Reply
Best4yourbuck
Best4yourbuck Mar. 24 at 10:34 AM
$AGRX f this stock lost so much in this
0 · Reply
Stock_Guy_69
Stock_Guy_69 Feb. 24 at 9:04 PM
$AGRX $SENS So blessed! 🤣
1 · Reply
dln101
dln101 Feb. 6 at 1:35 PM
$AVGR depending on where it opens may get some for a bounce 🤔 $AGRX 🔥📈
1 · Reply
NVDAistheSHIZ
NVDAistheSHIZ Feb. 4 at 2:23 PM
$CODX $AGRX https://www.stocktitan.net/news/TNXP/tonix-pharmaceuticals-announces-1-for-100-reverse-stock-py8xwkged9yd.html This is the type of BS that happens in the drug world...don't invest in this sector...never
1 · Reply
NVDAMillionaire
NVDAMillionaire Jan. 25 at 3:00 PM
$AGRX Agile Therapeutics, Inc. (AGRX): Executing on Commercialization Strategy, Poised for Continued Growth https://beyondspx.com/article/agile-therapeutics-inc-agrx-executing-on-commercialization-strategy-poised-for-continued-growth
0 · Reply
CanadianApe69
CanadianApe69 Jan. 23 at 4:42 PM
$DWTX $AGRX and $HOTH
0 · Reply
Morgo
Morgo Dec. 23 at 2:20 PM
$AGRX 👀
0 · Reply
_802016493_
_802016493_ Dec. 17 at 2:16 AM
$INTC if they name a guy name Al Altomari as CEO I'll be 100% out that second ($AGRX)
1 · Reply
wd122
wd122 Nov. 23 at 7:49 PM
$AGRX put all my agrx profits into $WVTRS.X . Big things coming in 2025.
1 · Reply
Manjunk
Manjunk Nov. 5 at 4:38 AM
$AGRX how's Super Mario these days 🫣
1 · Reply
stkmkt
stkmkt Oct. 22 at 5:18 PM
$AGRX just saw in GMA news... Biden administration expanding birth control acess... too bad $AGRX couldn't take advantage of programs like this.
1 · Reply
Jeff123123
Jeff123123 Oct. 3 at 4:36 PM
$AGRX Demons, pay 3000 times or More or go to HELL forever.
0 · Reply
Gettingpaid2021
Gettingpaid2021 Sep. 30 at 1:35 AM
$AGRX $67,000 invest to be paid $728. Fuck AL
3 · Reply
glove_33
glove_33 Sep. 24 at 1:34 PM
$AGRX Good riddens. I’ve been bashing the hell out of this POS for years after getting suckered in myself. What was interesting is that the Bulls wouldn’t listen to a single Bearish rational comment. They would justify, make excuses, and keep buying at every new all time low all the way to the bottom of the never ending cesspool. Happy this is my last bearish post on this garbage before I formally said good buy and delete this clown of a ticker off my watchlist. It was an expensive lesson.
1 · Reply
glove_33
glove_33 Sep. 24 at 1:30 PM
$AGRX As of August 2024, Agile Therapeutics (AGRX) is no longer publicly traded. The company was acquired by Insud Pharma, a global pharmaceutical group, in a deal valued at approximately $45 million. As part of the acquisition, shareholders of Agile Therapeutics received $1.52 per share. After the transaction, Agile merged with Exeltis USA (a subsidiary of Insud), and the company has been delisted from public markets, including the OTCQB
0 · Reply
Billno
Billno Sep. 5 at 2:59 PM
$AGRX Wow ! Is all I can Say ! Once again the,VOTE OF SHAREHOLDERS , Meant Nothing and Destroyed Shareholder Value so bod ,and Market makers, and predatory Hedgefunds can profit off the Backs of Retail. All While GARY GENSLER, @Sec .turns his head , takes his cut, tells everyone OH No ! Everything's GREAT.
1 · Reply
bigshepherdd
bigshepherdd Sep. 2 at 11:07 PM
$AGRX GME🟢GME🤑GME🤑🤑GME
0 · Reply